Rein Therapeutics Inc (RNTX)

$1.16 +0.04 (3.57%)
Market Cap 32.25M
Revenue (ttm) 0.00
Net Income (ttm) -49.87M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 529,857
Avg Vol 603,904
Day's Range N/A - N/A
Shares Out 28.04M
Stochastic %K 32%
Beta 1.42
Analysts Sell
Price Target $10.00

Company Profile

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The comp...

Industry: Biotechnology
Sector: Healthcare
Phone: 737 802 1989
Address:
12407 N. Mopac Expy., Suite 250 #390, Austin, United States
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 13 at 12:54 AM
$RNTX $AIRS $OPEN $RMCO
0 · Reply
TW_Research
TW_Research May. 10 at 1:41 PM
Portfolio now up 100% on the year and the future looking bright. Subscribe to the free newsletter to see what stocks we are following. $ALMU $KZIA $WATT $RNTX are the recent winners. But there are more.https://twresearchgroup.com/2026/05/the-bull-market-continues-into-micro-cap-earnings-week/
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 8 at 7:40 PM
$AIRS $RNTX $RMCO $OPEN - gonna print money all summer
1 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 8 at 1:34 AM
$TOI great earnings mgt - keep walking her up $AIRS - your up next $RNTX - loving the action - no brainer buy $OBIO - steady eddie - buy dips
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 7 at 11:23 AM
$RMCO $AIRS $CYPH $RNTX Is coming for them all!
0 · Reply
longterminvs
longterminvs May. 7 at 3:38 AM
$RNTX https://x.com/Rein_Tx/status/2052052039937531974?s=20
0 · Reply
TW_Research
TW_Research May. 7 at 2:18 AM
$RNTX Amazing how little interest there is here. That will change soon enough.
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 6 at 2:54 PM
$AIRS $KZIA $OBIO $RNTX Rntx - deal closed monday - starting to wake up - major catalyst less than 6'm Smart money & clean (derisked and no overhang w a clean cap table at 1$ - ill join em - no brainer Airs - wont be denied - space is heating up - shorts got this wrong Obio - great news today - i buy Kzia - up 100 percent and still holding
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 5 at 10:19 PM
$AIRS $CYPH $OPEN $RNTX
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 5 at 2:56 PM
$CYPH $RNTX $OPEN $AIRS Cyph - boom shakala New adds - airs and rntx Let the fun begin
0 · Reply
Latest News on RNTX
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

Apr 30, 2026, 8:00 PM EDT - 12 days ago

Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

Rein Therapeutics provides update on RENEW clinical trial

2026-04-29T14:52:11.000Z - 14 days ago

Rein Therapeutics provides update on RENEW clinical trial

Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis

Apr 29, 2026, 8:00 AM EDT - 14 days ago

Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics files to sell 30M shares of common stock

2026-04-28T21:45:51.000Z - 14 days ago

Rein Therapeutics files to sell 30M shares of common stock

Rein Therapeutics past the regulatory uncertainty, says H.C. Wainwright

2026-04-02T15:00:37.000Z - 5 weeks ago

Rein Therapeutics past the regulatory uncertainty, says H.C. Wainwright

Rein Therapeutics doses first patient in Phase 2 trial of LTI-03

2026-03-03T13:18:26.000Z - 2 months ago

Rein Therapeutics doses first patient in Phase 2 trial of LTI-03

Rein Therapeutics downgraded to Hold from Buy at Brookline

2026-01-21T14:20:17.000Z - 4 months ago

Rein Therapeutics downgraded to Hold from Buy at Brookline

Rein Therapeutics receives orphan drug designation from EMA for LTI-03

2026-01-20T13:12:26.000Z - 4 months ago

Rein Therapeutics receives orphan drug designation from EMA for LTI-03

Rein Therapeutics announces publication on LTI-03

2025-11-06T13:27:27.000Z - 6 months ago

Rein Therapeutics announces publication on LTI-03

Rein Therapeutics upgraded to Buy from Hold at Brookline

2025-11-03T17:55:07.000Z - 6 months ago

Rein Therapeutics upgraded to Buy from Hold at Brookline

Rein Therapeutics receives FDA clearance to resume Phase 2 trial of LTI-03

2025-11-03T12:36:11.000Z - 6 months ago

Rein Therapeutics receives FDA clearance to resume Phase 2 trial of LTI-03

Rein receives European regulatory approval to initiate Phase 2 trial of LTI-03

2025-10-09T11:36:09.000Z - 7 months ago

Rein receives European regulatory approval to initiate Phase 2 trial of LTI-03

Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Oct 9, 2025, 7:30 AM EDT - 7 months ago

Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics initiated with a Buy at H.C. Wainwright

2025-09-22T10:10:15.000Z - 8 months ago

Rein Therapeutics initiated with a Buy at H.C. Wainwright

Rein Therapeutics announces publication of data on LTI-03 in IPF

2025-09-17T11:35:19.000Z - 8 months ago

Rein Therapeutics announces publication of data on LTI-03 in IPF

Rein Therapeutics Announces Publication of New Translational Data in iScience on Company's Novel Therapy for Idiopathic Pulmonary Fibrosis

Sep 17, 2025, 7:30 AM EDT - 8 months ago

Rein Therapeutics Announces Publication of New Translational Data in iScience on Company's Novel Therapy for Idiopathic Pulmonary Fibrosis

Rein Therapeutics files to sell 10M shares of common stock for holders

2025-09-03T21:05:11.000Z - 9 months ago

Rein Therapeutics files to sell 10M shares of common stock for holders

Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial

2025-08-19T12:05:29.000Z - 9 months ago

Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Aug 19, 2025, 8:00 AM EDT - 9 months ago

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics downgraded to Hold from Buy at Brookline

2025-08-19T09:05:31.000Z - 9 months ago

Rein Therapeutics downgraded to Hold from Buy at Brookline

Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025

Aug 14, 2025, 5:00 PM EDT - 9 months ago

Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025

Rein Therapeutics enters agreements for up to $21M in financing

2025-07-30T12:36:02.000Z - 10 months ago

Rein Therapeutics enters agreements for up to $21M in financing

Rein Therapeutics Transcript: AGM 2025

Jul 23, 2025, 9:00 AM EDT - 10 months ago

Rein Therapeutics Transcript: AGM 2025

Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Jun 24, 2025, 10:11 AM EDT - 11 months ago

Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders

US FDA puts on hold Rein Therapeutics' lung disease drug trial

Jun 12, 2025, 5:18 PM EDT - 11 months ago

US FDA puts on hold Rein Therapeutics' lung disease drug trial

Rein Therapeutics says first patient dosed in Renew Phase 2 trial of LTI-03

2025-05-27T11:05:11.000Z - 1 year ago

Rein Therapeutics says first patient dosed in Renew Phase 2 trial of LTI-03

IQV

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

May 27, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

IQV

Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference

May 19, 2025, 4:51 PM EDT - 1 year ago

Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference

Rein Therapeutics files $150M mixed securities shelf

2025-05-16T13:34:22.000Z - 1 year ago

Rein Therapeutics files $150M mixed securities shelf

Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025, 4:09 PM EDT - 1 year ago

Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

May 12, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

Rein Therapeutics Transcript: The Citizens JMP Life Sciences Conference 2025

May 8, 2025, 12:00 PM EDT - 1 year ago

Rein Therapeutics Transcript: The Citizens JMP Life Sciences Conference 2025

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

May 1, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

Apr 28, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases

Apr 23, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases

Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F

Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Apr 7, 2025, 4:17 PM EDT - 1 year ago

Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 13 at 12:54 AM
$RNTX $AIRS $OPEN $RMCO
0 · Reply
TW_Research
TW_Research May. 10 at 1:41 PM
Portfolio now up 100% on the year and the future looking bright. Subscribe to the free newsletter to see what stocks we are following. $ALMU $KZIA $WATT $RNTX are the recent winners. But there are more.https://twresearchgroup.com/2026/05/the-bull-market-continues-into-micro-cap-earnings-week/
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 8 at 7:40 PM
$AIRS $RNTX $RMCO $OPEN - gonna print money all summer
1 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 8 at 1:34 AM
$TOI great earnings mgt - keep walking her up $AIRS - your up next $RNTX - loving the action - no brainer buy $OBIO - steady eddie - buy dips
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 7 at 11:23 AM
$RMCO $AIRS $CYPH $RNTX Is coming for them all!
0 · Reply
longterminvs
longterminvs May. 7 at 3:38 AM
$RNTX https://x.com/Rein_Tx/status/2052052039937531974?s=20
0 · Reply
TW_Research
TW_Research May. 7 at 2:18 AM
$RNTX Amazing how little interest there is here. That will change soon enough.
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 6 at 2:54 PM
$AIRS $KZIA $OBIO $RNTX Rntx - deal closed monday - starting to wake up - major catalyst less than 6'm Smart money & clean (derisked and no overhang w a clean cap table at 1$ - ill join em - no brainer Airs - wont be denied - space is heating up - shorts got this wrong Obio - great news today - i buy Kzia - up 100 percent and still holding
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 5 at 10:19 PM
$AIRS $CYPH $OPEN $RNTX
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 5 at 2:56 PM
$CYPH $RNTX $OPEN $AIRS Cyph - boom shakala New adds - airs and rntx Let the fun begin
0 · Reply
10baggerPete
10baggerPete May. 4 at 10:32 PM
$RNTX 3 day rule, ya cheeky pups!
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 4 at 1:45 PM
$AIRS $RNTX $OBIO $KZIA All looking good and just gonna get better
1 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 1 at 9:40 PM
So good for $KZIA and the space .. just entered $AIRS $RNTX.... let the fun begin
0 · Reply
TW_Research
TW_Research May. 1 at 8:34 PM
$RNTX Only 157 watchers on here. Reminds me of when I started following $KZIA or $ALMU. I was one of only a few people tracking the stocks and therein lies the opportunity. Raising $50 million from high quality funds resets this company and positions it for a nice run into data. Enrollment exceeding expectations and y'all should start paying attention to it. My guess is nice run from here once the stock settles in post the financing. As always, do your own DD.
1 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 1 at 3:19 PM
$RNTX $KZIA $OBIO $TOI Same turnaround guys who did kzia just went clean on rntx and whales loading there boats w smart money - perhaps I will join em Fully funded and no overhangs to deal with and data in November Sure why not..
0 · Reply
OpenOutcrier
OpenOutcrier May. 1 at 12:51 PM
$RNTX (-19.1% pre) Rein Therapeutics prices $50 million public offering at $1 per share https://ooc.bz/l/100821
0 · Reply
DARKP00L
DARKP00L Apr. 29 at 12:20 PM
$RNTX 08:02 on Apr. 29 2026 Rein Therapeutics Enrolled 8 Patients In RENEW Trial #tradeideas
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 28 at 8:15 PM
$RNTX
0 · Reply
MisterBean26
MisterBean26 Apr. 22 at 5:30 PM
$RNTX 🫵🏻
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 16 at 12:45 AM
$RNTX RSI: 75.53, MACD: 0.1042 Vol: 0.17, MA20: 1.38, MA50: 1.27 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MomentumWins
MomentumWins Apr. 8 at 1:47 PM
$SPY $QQQ $RNTX - Rntx chart setup is top notch…
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Apr. 7 at 8:01 PM
$RNTX yup + $SPWH $ACIU
0 · Reply